Tracey Mason Selected Research

human TGFB3 protein

9/2011	Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring.
7/2011	Avotermin for scar improvement following scar revision surgery: a randomized, double-blind, within-patient, placebo-controlled, phase II clinical trial.
11/2010	Scar-improving efficacy of avotermin administered into the wound margins of skin incisions as evaluated by a randomized, double-blind, placebo-controlled, phase II clinical trial.
1/2010	Therapies with emerging evidence of efficacy: avotermin for the improvement of scarring.
4/2009	Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tracey Mason Research Topics

Disease

7	Cicatrix (Scar) 05/2013 - 02/2008
6	Wounds and Injuries (Trauma) 05/2013 - 02/2008
1	Inflammation (Inflammations) 05/2013
1	Erythema 04/2009

Drug/Important Bio-Agent (IBA)

5	human TGFB3 proteinIBA 09/2011 - 04/2009
3	CytokinesIBA 05/2013 - 01/2010
3	Transforming Growth Factor beta (TGF-beta)IBA 09/2011 - 01/2010
2	CollagenIBA 07/2011 - 04/2009
1	Interleukin-4 (Interleukin 4)IBA 05/2013
1	Interleukin-10 (Interleukin 10)IBA 05/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2011
1	Transforming Growth Factor beta3 (TGF beta 3)IBA 04/2009
1	Pharmaceutical PreparationsIBA 02/2008

Therapy/Procedure

3	Therapeutics 09/2011 - 04/2009
2	Reoperation 07/2011 - 01/2010
1	Intradermal Injections 11/2010
1	Injections 11/2010